Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG

Pediatric Blood and Cancer

Volumn 53, Issue 4, 2009, Pages 563-569

  Okamatsu, Chizuko ^a,b   London, Wendy B ^c   Naranjo, Arlene ^c   Hogarty, Michael D ^d   Gastier Foster, Julie M ^e,f   Look, A Thomas ^g   LaQuaglia, Michael ^h   Maris, John M ^d   Cohn, Susan L ⁱ   Matthay, Katherine K ^j   Seeger, Robert C ^a   Saji, Tsutomu ^b   Shimada, Hiroyuki ^a,k  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^c UNIVERSITY OF FLORIDA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e NATIONWIDE CHILDREN S HOSPITAL   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k CHILDREN S HOSPITAL LOS ANGELES   (United States)

more..

Author keywords

Clinical staging; Ganglioneuroblastoma; Ganglioneuroma; International Neuroblastoma Pathology Classification; Prognosis; Tumor resectability

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SURGERY; CHILD; CONTROLLED STUDY; DEATH; DIPLOIDY; DISTANT METASTASIS; FLOW CYTOMETRY; GANGLIONEUROMA; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; CANCER STAGING; GENETICS; MORTALITY; PATHOLOGY;

MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; INFANT; NEOPLASM STAGING; NUCLEAR PROTEINS; ONCOGENE PROTEINS;

EID: 69849091302     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22106     Document Type: Article

References (30)

1. Beckwith JB, Martin RF. Observations on the histopathology of neuroblastomas. J Pediatr Surg 1968;3:106-110.
2. Hughes M, Marsden HB, Palmer MK. Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 1974;34:1706-1711.
3. Shimada H, Chatten J, Newton WA, et al. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-416. (Pubitemid 14055221)
4. Dehner LP. Classic neuroblastoma: Histopathologic grading as a prognostic indicator, The Shimada System and its progenitors. Am J Pediatr Hematol Oncol 1988;10:143-154.
5. Joshi VV, Rao PV, Cantor AB, et al. Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. Cancer 1996;77:1582-1588.
6. Joshi VV, Tsongalis GJ. Correlation between morphologic and nonmorphologic prognostic markers of neuroblastoma. Ann NY Acad Sci 1997;824:71-83.
7. Shimada H, Ambros IM, Dehner LP, et al. Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999;86:349-363. (Pubitemid 29327593)
8. Shimada H, Ambros IM, Dehner LP, et al. The international neuroblastoma pathology classification (the Shimada system). Cancer 1999;86:364-372. (Pubitemid 29327594)
9. Ambros IM, Hata J, Joshi VV, et al. Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups. Cancer 2002;94:1574-1583. (Pubitemid 34212653)
10. Brodeur GM. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-216. (Pubitemid 37328872)
11. Hayes FA, Green AA, Rao BN. Clinical manifestations of ganglioneuroma. Cancer 1989;63:1211-1214.
12. De Bernardi B, Gambini C, Haupt R, et al. Retrospective study of childhood ganglioneuroma. J Clin Oncol 2008;26:1710-1716.
13. Robertson HE. Das Ganglioneuroblastom ein besonederer Typus im System der Neurome. Virchows Arch [Pathol Anat] 1915;63:147-168.
14. Stout AP. Ganglioneuroma of the sympathetic nervous system. Surg Gynecol Obstet 1947;83:101-110.
15. Bove KE, McAdams AJ. Composite ganglioneuroblastoma, an assessment of the significance of histological maturation in neuroblastoma diagnosed beyond infancy. Arch Pathol Lab Med 1981;105:325-330.
16. Peuchmar M, d'Amore ESG, Joshi VV, et al. Revision of the international neuroblastoma pathology classification. Confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 2003;98:2274-2281.
17. Brodeur GM, Prichard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-1477. (Pubitemid 23228250)
18. Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Oncologist 2003;8:278-292.
19. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-1173.
20. Matthay KK, Perez K, Seeger RC, et al. Successful treatment of stage III neuroblastoma baced on prospective biologic staging: A Children's Cancer Group study. J Clin Oncol 1998;16:1256-1264.
21. Perez C, Matthay KK, Atkinson JB, et al. Biologic variables in the outcome of stage I and II neuroblastoma treated with surgery as primary therapy: A Children's Cancer Group study. J Clin Oncol 2000;18:18-26. (Pubitemid 30036332)
22. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
23. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II: Analysis and Examples. Br J Cancer 1977;35:1-39. (Pubitemid 8018922)
24. Schmidt ML, Salwen HR, Chagnovich D, et al. Evidence of molecular heterogeneity in human ganglioneuroblastoma. Pediatr Pathol 1993;13:787-796. (Pubitemid 23343985)
25. Look AT, Hayes AF, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group Study. J Clin Oncol 1991;9:581-591.
26. Goto S, Umehara S, Gerbing RB, et al. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. A report from the Children's Cancer Group. Cancer 2001;92:2699-2708.
27. Oppedal BR, Storm-Mathisen I, Lie SO, et al. Prognostic factors in neuroblastoma: Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer 1988;62:772-780. (Pubitemid 18186106)
28. Mora J, Cheung NK, Juan G, et al. Neuroblastic and schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res 2001;61:6892-6898. (Pubitemid 32896515)
29. Ambros IM, Zellner A, Roald B, et al. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 1996;334:1501-1511. (Pubitemid 26166893)
30. Du W, Hozumi N, Sakamoto M, et al. Reconstitution of schwannian stroma in neuroblastomas using human bone marrow stromal cells. Am J Pathol 2008;173:1153-1164.